Jennerex Biotherapeutics Company Profile

Aggregated data from the web about Jennerex Biotherapeutics

Company Name	Jennerex Biotherapeutics
Website	www.sillajen.com
Snippet	Pexa-Vec is the most advanced product candidate from SillaJen’s proprietary SOLVE™ (Selective Oncolytic Vaccinia Engineering) platform. The vaccinia virus backbone (Wyeth strain) of Pexa-Vec has been used safely in millions of people as part of a worldwide vaccination program to eradicate smallpox.
Type	Private[1]
Owner	SillaJen, Inc.
Founder	David H. Kirn[1]
Website	http://www.sillajen.com
Industry	Biopharmaceuticals
Products	Pexa-Vec (JX-594), JX-929[1]
linkedin	linkedin.com/company/jennerex-biotherapeutics
size_range	11 - 50
Headquarters	450 Sansome Street, 16th Floor, San Francisco, California, U.S.[2]
Number of employees	~50
Number of locations	4 (USA, Canada, South Korea)

Jennerex Biotherapeutics is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.